LFMD · XBRL financial data

LifeMD financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (LFMD's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Mar 11, 2024	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	37,294	92,876	119,034	—	212,454	194,055
Cost of revenue	8,907	17,995	18,668	—	24,068	27,715
Gross profit	28,386	74,880	100,365	—	188,385	166,340
General and administrative	42,207	39,570	46,961	—	72,662	57,937
Total operating expenses	86,206	129,181	143,813	—	204,530	174,010
Operating income (loss)	(57,819)	(54,301)	(43,448)	—	(16,145)	(7,670)
Interest expense	1,668	3,020	1,276	—	2,182	1,361
Income tax expense (benefit)	123	8	361	—	402	46
Net income (loss)	(58,647)	(60,898)	(45,536)	—	(18,882)	14,354
Earnings per share, basic USD per share	—	—	—	—	(0.60)	0.25
Earnings per share, diluted USD per share	—	—	—	—	(0.60)	0.25
Weighted average shares, basic thousands of shares	14,275	27,008	30,976	—	41,196	45,130
Weighted average shares, diluted thousands of shares	14,275	27,008	30,976	—	41,196	45,130

Fiscal years (LFMD's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Mar 11, 2024	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	9,179	41,328	3,959	26,400	35,005	36,786
Accounts receivable	648	980	2,835	—	8,218	9,305
Inventory	1,264	1,617	3,703	—	2,797	2,774
Total current assets	12,063	44,921	11,311	—	48,733	51,831
Property and equipment, net	—	234	476	—	1,479	2,445
Right-of-use asset	274	1,752	1,206	—	6,401	5,268
Goodwill	—	0	0	—	—	—
Total assets	13,054	49,923	25,666	—	72,460	70,411
Accounts payable	10,408	9,059	10,107	—	16,009	14,149
Accrued liabilities	—	11,596	12,167	—	20,812	15,974
Total current liabilities	13,490	22,826	31,374	—	60,255	41,573
Lease liability, non-current	192	1,179	574	—	6,265	5,681
Total liabilities	13,875	24,104	32,971	—	76,505	47,255
Accumulated deficit	(80,152)	(141,921)	(190,563)	—	(236,253)	(228,603)
Total stockholders' equity	(2,302)	22,740	(11,396)	—	(5,486)	23,157
Total liabilities and equity	13,054	49,923	25,666	—	72,460	70,411
Common shares outstanding (cover page) thousands of shares	25,907	30,833	31,887	40,366	44,584	47,974

Fiscal years (LFMD's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Mar 11, 2024	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(58,647)	(60,898)	(45,536)	—	(18,882)	14,354
Stock-based compensation	18,656	12,072	13,735	—	12,235	10,496
Net cash from operating activities	(12,132)	(33,085)	(22,935)	—	17,513	8,280
Purchases of property and equipment	—	247	367	—	1,491	1,871
Net cash from investing activities	(798)	(3,402)	(13,906)	—	(11,536)	6,908
Proceeds from issuing common stock	2,338	493	—	—	—	8,722
Proceeds from issuing equity	—	55,300	—	—	—	—
Share repurchases	—	—	—	—	—	270
Dividends paid	—	871	3,106	—	3,106	3,106
Net cash from financing activities	21,002	68,637	(528)	—	(4,119)	(13,407)
Net change in cash	8,072	32,149	(37,369)	—	1,858	1,781

SIC 8011 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.

How peers are chosen

SIC 8011 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Fewer than three companies fall in that range, so the list adds same-SIC (8011) companies nearest in public float, each marked “added: same SIC”.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.
A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
LifeMD	25,142	47,281	(6,926)*	48.2M	3.6 quarters	Q2 FY26 10-QJun 30, 2026
Teladoc Health	849,909	605,102	106,458*	182.3M	—	Q3 FY26 10-QSep 30, 2026
Starling Oncology	41,094	161,282	11,940*	101.9M	—	Q2 FY26 10-QJun 30, 2026
Airsculpt Technologiesadded: same SIC	18,824	42,900	(1,238)*	72.1M	15.2 quarters	Q2 FY26 10-QJun 30, 2026
SBC Medical Group Holdingsadded: same SIC	184,311	49,188	22,509*	102.8M	—	Q2 FY26 10-QJun 30, 2026
Cardiff Lexingtonadded: same SIC	218	2,160	(652)*	15.6M	0.3 quarters	Q2 FY26 10-QJun 30, 2026
Hims & Hers Healthadded: same SIC	609,811	753,214	(35,939)*	not reported	—	Q2 FY26 10-QJun 30, 2026
HealthLynkedadded: same SIC	13	not reported	(350)*	3.0M	0.0 quarters	Q2 FY26 10-QJun 30, 2026
Aunaadded: same SIC	235,745	year only	year only	not reported	—	Q4 FY24 20-F/ADec 31, 2024

Not investment advice. Not affiliated with the U.S. SEC.